{"task_id": "9340a14e183e969c", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 84/464)", "text": "INVESTIGATION ISSUES\nAcute Renal Failure: Renal\n69\n\n--- Page 91 ---\nSPECIFIC ENTITIES (CONT\u2019D)\nbefore until 6 h after contrast exposure; (3) IV N\nacetylcysteine 150 mg/kg in 500 mL 0.9% NS given\n30 min before contrast exposure, followed by\nSPECIFIC ENTITIES (CONT\u2019D)\n50 mg/kg in 500 mL 0.9% NS IV given over 4 h after\n(alternatively, N acetylcysteine 600 mg PO BID on\nday of and day after contrast exposure)\nAcute Renal Failure: Post-renal\nDIFFERENTIAL DIAGNOSIS\nURETHRA\nstricture, stenosis\nPROSTATE\nBPH, prostatitis, cancer\nBLADDER\ncancer, stones, clots, neurogenic\nURETERS (bilateral involvement)\n\u0002\nINTRALUMINAL\ncancer, stones, clots, papillary\nnecrosis\n\u0002\nEXTRALUMINAL\ncancer, retroperitoneal fibrosis,\npregnancy\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, Cr/urea, urinalysis\n\u0002\nIMAGING\nU/S abd/pelvis\nINVESTIGATIONS (CONT\u2019D)\nSPECIAL\n\u0002\nPOST-RESIDUAL VOLUME\n>200 mL suggests\nobstruction\n\u0002 CT ABD/KUB/IVP\nif suspect stones or tumors\n\u0002\nDIURESIS RENOGRAPHY OR UROGRAPHY\nDIAGNOSTIC ISSUES\nRENAL U/S\nhydronephrosis suggests post renal\ncauses. However, retroperitoneal fibrosis and acute\npost renal obstruction may not show hydronephrosis\nMANAGEMENT\nTREAT UNDERLYING CAUSE\nFoley catheter. For\nBPH (tamsulosin 0.4 mg PO daily or TURP)\nRENAL REPLACEMENT\ndialysis (peritoneal, hemo\ndialysis)\nGlomerulopathies\nPATHOPHYSIOLOGY OF GLOMERULOPATHIES\nAUTOIMMUNE PHENOMENON\nantibodies binding\nto structural components of glomeruli (more glomerular\nbasement membrane and podocytes involvement in\nnephrotic syndrome, more mesangium and endothe\nlium involvement in nephritic syndrome), circulating\nantigen antibody complexes, and/or cell mediated\nPATHOPHYSIOLOGY OF GLOMERULOPATHIES (CONT\u2019D)\nimmunity ! further immune activation and damage\nto glomeruli\nPATHOLOGY TERMS\nfocal=<50% of glomeruli,\ndiffuse=>50% of glomeruli, segmental=segment\nof glomerulus, global=entire glomerulus\nCLINICAL FEATURES\nCLINICAL MANIFESTATIONS OF GLOMERULAR DISEASES\nClinical manifestation\nExamples\nAsymptomatic proteinuria\nFSGS, mesangial proliferative GN, diabetic nephropathy\nNephrotic syndrome\nMCD, FSGS, MGN, MPGN, amyloidosis, light chain deposition disease,\ndiabetic nephropathy\nAsymptomatic hematuria\nThin basement membrane disease, IgA nephropathy, Alport\u2019s syndrome\nRecurrent gross hematuria\nThin basement membrane disease, IgA nephropathy, Alport\u2019s syndrome\nAcute nephritis\nPost infectious GN, IgA nephropathy, lupus nephritis, MPGN\nRapidly progressive glomerular\nnephritis (RPGN)\nSee text\nPulmonary renal syndrome\nAntiglomerular basement membrane antibody disease, immune\ncomplex vasculitis, pauci immune (ANCA) vasculitis\nChronic renal failure\nSclerosed glomerular disease\n70\nGlomerulopathies", "text_length": 2661, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 84/464)", "type": "chunk", "chunk_index": 83, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.355471", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.356185", "status": "complete", "chunks_added": 2}